4.7 Review

Dealing with nanosafety around the globe-Regulation vs. innovation

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 509, 期 1-2, 页码 95-106

出版社

ELSEVIER
DOI: 10.1016/j.ijpharm.2016.05.015

关键词

Nanomaterials; Nanoparticles; Regulations; EMA; ANVISA; EFSA; OECD; Rules; Law

资金

  1. LOEWE initiative of the State of Hessen

向作者/读者索取更多资源

In recent years, nanotechnology has become increasingly important for global industries. Today, many nanomaterials are used as ingredients in cosmetics, food products, medical devices and pharmaceuticals. In some cases they exert unexpected risks and potentially pose a threat to human health and the environment. Regulatory authorities all over the world carefully observe recent developments in this area, striving to find a balance between consumer safety and the interests of the industry. In the following, the current legislation in the United States of America, the European Union, Asia and Brazil will be presented. Further, the requirements defined by these different authorities and methodology to investigate relevant characteristics of nanomaterials will be discussed. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据